GlassScriptPhysician profile
William D Sudduth
NPI 1013954718
$533.97
in general payments reported to CMS, 2019-2025
15 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.04 · 2020: $26.91 · 2021: $97.41 · 2022: $46.64 · 2023: $125 · 2024: $66.53 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $103.94 | 2024-2025 | Sprint Pns System |
| Boston Scientific Corporation | $75.29 | 2022-2025 | Spectra Wavewriter |
| Scilex Pharmaceuticals INC. | $66.11 | 2021-2023 | Ztlido |
| Vericel Corporation | $39.04 | 2019 | |
| Smith+Nephew, INC. | $34.78 | 2025 | |
| Pacira Therapeutics, INC. | $33.32 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $30.81 | 2022-2023 | Zilretta, Iovera, Exparel |
| Heraeus Medical, LLC. | $26.91 | 2020 | |
| Solventum Corporation | $20.25 | 2025 | Prevena, V.A.C. Veraflo |
| Vertos Medical, INC. | $20.15 | 2023 | Mild Device Kit |
| Saluda Medical Americas, INC. | $17.86 | 2023 | Evoke Scs |
| Ibsa Pharma INC. | $17.61 | 2021 | |
| Amgen INC. | $17.38 | 2024 | Krystexxa |
| Avanos Medical | $17.10 | 2023 | Trivisc Sodium Hyaluronate |
| Redhill Biopharma INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sudduth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.